Dr. Nataliya Mar, MD
Claim this profileUC Irvine Health/Chao Family Comprehensive Cancer Center
Studies Skin Cancer
Studies Bladder Cancer
10 reported clinical trials
20 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
HER2 positive
2Bladder Cancer
Stage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Nataliya Mar, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
More about Nataliya Mar, MD
Clinical Trial Related2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Nataliya Mar, MD has experience with
- Nivolumab
- Eribulin Mesylate
- Sacituzumab Govitecan
- Diagnostic TURBT
- MpMRI
- Cemiplimab
Breakdown of trials Nataliya Mar, MD has run
Skin Cancer
Bladder Cancer
Transitional Cell Carcinoma
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nataliya Mar, MD specialize in?
Nataliya Mar, MD focuses on Skin Cancer and Bladder Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Nataliya Mar, MD currently recruiting for clinical trials?
Yes, Nataliya Mar, MD is currently recruiting for 7 clinical trials in Orange California. If you're interested in participating, you should apply.
Are there any treatments that Nataliya Mar, MD has studied deeply?
Yes, Nataliya Mar, MD has studied treatments such as Nivolumab, Eribulin Mesylate, Sacituzumab Govitecan.
What is the best way to schedule an appointment with Nataliya Mar, MD?
Apply for one of the trials that Nataliya Mar, MD is conducting.
What is the office address of Nataliya Mar, MD?
The office of Nataliya Mar, MD is located at: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California 92868 United States. This is the address for their practice at the UC Irvine Health/Chao Family Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.